News

Inder Paul Singh, MD, emphasized that patient compliance is a real and significant challenge in glaucoma care.

The review notes aesthetic considerations are increasingly important as social media and video conferencing spotlight facial appearance.

The ADVISE trial has demonstrated adalimumab’s superior management of intermediate uveitis, posterior uveitis, or panuveitis requiring immunosuppression.

Larissa Camejo, MD, emphasized that decisions are never “black and white” and must be individualized based on the specific patient.

Researchers examined 3 primary associations: the risk of developing uveitis following an IMID diagnosis, the odds of having a prior IMID among uveitis patients, and the risk of developing an IMID after a uveitis diagnosis.

Learn the latest on legislative updates from Arkansas, Texas, South Carolina, and Pennsylvania.

The company said the expansions support its goal of making evidence-based myopia management accessible to eye care professionals and children worldwide.

The clinical study will evaluate a noninvasive corneal strengthening procedure designed to reshape the cornea and correct refractive errors in-office without tissue removal.

A recent nonrandomized trial has demonstrated toric IOLs’ efficacy in providing long-term visual outcomes, reducing amblyopia compared to non-toric lenses.

Clocking in for Workplace Eye Wellness Month means knowing the environmental factors contributing to a patient's dry eye.

Rachon, OD, FAAO, DipABO, details her SECO 2026 poster presentation, "Treatment of Stage 1 NK Secondary to Acoustic Neuroma Removal with Cryopreserved Amniotic Membrane."

Cathleen McCabe, MD, details what can be done now for these patients in a sea of imperfect options.

According to a VSP Vision Care news release, 71% say they experience performance impacts due to screen-related visual discomfort, equating to nearly one full workday of lost productivity each week.

The FDA has assigned a PDUFA goal date of October 17, 2026.

A handful of MDs detail their presentations at this year's conference.

Vision rehabilitation includes training patients in the use of adaptive technologies, such as magnifiers or screen readers, and nonvisual techniques to facilitate the patients’ ability to complete daily tasks.

A recent study highlights the efficacy of the FAi implant in patients with NIU-related macular edema, improving BCVA and reducing choroidal thickness.

According to recent data, patients initiating semaglutide had a substantially greater risk of developing NAION versus those starting SGLT2 inhibitors.

Uveitis is a leading cause of blindness and accounts for an estimated 30,000 new cases of legal blindness annually in the US.

Rahul S. Tonk, MD, MBA, discussed his session on dry eye disease at EnVision Summit 2026, and looked ahead at the pipeline of therapies in development.

Alonso discusses his recent study highlighting pupil constriction in accommodative eye vergence as the central mechanism driving myopia progression.

Tonk, MD, MBA, references updates from TFOS DEWS III that promote standardized screening tools.

Pathik Amin, OD, FAAO, gave a presentation to the optometry cohort at the conference on glaucoma management, focusing on surgical options and recent advancements.

Julia Pulliam, OD, FAAO, highlights how working in an academic medical center provides significant advantages for managing complex conditions like uveitis.

The monthly multifocal toric lens with novel water gradient material targets presbyopic patients with astigmatism and is available to eye care professionals nationwide.